PHR2021
How medicines work 5: Drug delivery
基本信息
| 学分 | 6 credit points |
|---|---|
| 开课学期 | First semester |
| 校区 | Malaysia |
| 考核构成 | Close the Loop engagement — 5% Extemporaneous practicals — 5% In-semester MCQ/SAQ 1 — 10% Extemporaneous exam — 15% Formulation activity — 5% Pharmaceutical calculations quiz — 10% In-semester MCQ/SAQ 2 — 10% Final Examination — 40% |
开课安排1 条
| 教学期 | 授课方式 | 状态 |
|---|---|---|
| First semester | Teaching activities are on-campus (ON-CAMPUS) | 开课 |
以上为该校区在官方资料中登记的全部开课安排，不是汇总。同一门课可能在多个 教学期开课，也可能不同教学期的授课方式不同。
课程简介
This unit will provide you with a detailed understanding of the specific biopharmaceutical and formulation considerations for various drug delivery routes, including intravenous, subcutaneous, intramuscular, oral, transdermal, pulmonary, nasal, buccal, sublingual, rectal, vaginal and ocular routes and for targeted and modified drug delivery. This unit will also address specific issues to be considered when formulating and dispensing medicines and the differences in quality, activity and toxicity that may arise from variability in manufacturing and formulation processes, with a focus on Good Manufacturing Practice. This unit will also highlight the innovative formulation approaches that are currently under investigation for the targeted delivery of therapeutics.
以上为 Monash Handbook 的官方原文，版权属 Monash University，此处按本站要求转载并标注出处： 官方页面 ↗
学习成果8 条
官方原文（Learning outcomes），版权属 Monash University。
- ULO1 Explain the importance of drug properties, clinical need and desired therapeutic outcome on the choice of dosage form and route of administration for a particular medicine
- ULO2 Describe the biopharmaceutical barriers that apply to various routes of administration
- ULO3 When changing routes of administration, calculate the correct dose required to obtain the same therapeutic effect
- ULO4 Given a formulation, explain the rationale for the dosage form and inclusion of each of the excipients
- ULO5 Prepare common formulations encountered in a pharmacy setting
- ULO6 Describe the development and formulation principles for a stable therapeutic macromolecule
- ULO7 Analyse Quality Assurance and Good Manufacturing Practices and interpret how they apply to compounding
- ULO8 Demonstrate proficiency in fundamental pharmaceutical calculations
教学方式与预期工作量
教学方式
Active learning
预期工作量
• Seventy-two hours of independent study
• Twenty-four hours of pre-learning activities (up to 2 hours per week)
• Twenty-four hours of active learning lectures (2 hours a week)
• Twenty-four hours of small group classes including assessment (2 hours per week)
官方原文，版权属 Monash University。
先修 / 同修要求
以下先修关系按官方来源的结构化先修字段解析，原始记号：PHR1011 AND PHR1021 AND PHR1031 AND PHR1012 AND PHR1022 AND PHR1122 AND PHR1222
修完这门课可以衔接
先修链路
按官方先修字段的原始分组展开，AND / OR 的区别保留着—— 「A 或 B」和「A 与 B」在选课时是两回事。每门课点进去可以继续往下看。
属于这些学位1 个
这门课出现在下列学位的官方结构里。反过来说：如果你读的是这些学位之一，它大概率是要修的 （必修还是选修取决于它在 Part 里的位置，点进去看结构）。
数据来源
- 数据来源
- 官方网页
handbook.monash.edu ↗ - 抓取时间
- 2026-09-13
- 可信度
- 程序抓取，未人工核实
查看官方完整描述 ↗ — 事实性字段（代码、学分、教学期、授课方式、考核权重、先修/同修/互斥关系）与 课程简介、学习成果、教学方式、预期工作量均取自官方 Handbook； 正文版权属 Monash University，此处转载并逐处标注出处。
发现信息有误？告诉我们。请用自己的话描述问题，不要上传成绩单、截图或校内系统文件。